News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Nobel Biocare: Continued Strong Revenue Growth After Nine Months -- U.S. Business Regaining Momentum; Additional Cash Return to Shareholders in 2007
October 30, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Switzerland, Oct. 30, 2007 (PRIME NEWSWIRE) -- First nine-months highlights:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Sickle cell disease
Fulcrum lays off 85% of staff after dropping asset, leaving 9 employees
June 5, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
June 4, 2026
·
2 min read
·
Nick Paul Taylor
IPO
Peptide biotech Parabilis targets up to $476M IPO
June 4, 2026
·
2 min read
·
Gabrielle Masson
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
June 4, 2026
·
1 min read
·
Tristan Manalac